Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",49698,300,2.57 [2.07-3.18],5.152977638744072e-18
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51496,398,1.81 [1.49-2.20],2.484070122876003e-09
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",50960,2782,1.97 [1.83-2.12],7.556990737226319e-72
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Candidiasis,51539,863,2.00 [1.75-2.28],4.618921680600846e-25
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,49973,7035,1.70 [1.62-1.78],1.7777667245032878e-98
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),50161,6425,2.00 [1.90-2.10],1.0463014169420933e-161
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,51027,2443,1.85 [1.71-2.01],2.4627827195500724e-50
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,51350,173,2.81 [2.16-3.66],1.9363601200147284e-14
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,47409,1954,2.58 [2.36-2.81],2.083174830435691e-99
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,45801,2220,2.97 [2.75-3.21],9.24600086840104e-162
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,45543,517,3.45 [2.93-4.07],1.863243832130624e-49
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,36225,3986,2.09 [1.96-2.22],7.540103448167173e-116
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,45245,788,3.53 [3.10-4.02],4.272188690711254e-80
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,51464,2880,1.79 [1.66-1.93],3.517725018331357e-53
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Mycoses,51693,1017,1.92 [1.70-2.17],7.514783180978308e-26
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,50050,1872,2.18 [2.00-2.38],6.9876339069954416e-68
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,51552,2154,2.28 [2.10-2.47],1.270483420830904e-87
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48984,400,1.87 [1.54-2.28],4.995759834323044e-10
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,51793,100,1.99 [1.34-2.93],0.0005715884027115
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,51284,1886,2.31 [2.11-2.52],2.956539964869161e-79
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51331,154,1.17 [0.83-1.65],0.3588323084742248
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51630,315,1.93 [1.55-2.40],4.869325381087282e-09
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51591,276,1.81 [1.42-2.30],1.3146238337963702e-06
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,49024,846,2.49 [2.19-2.83],1.2515289706603937e-43
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,48733,555,1.99 [1.67-2.36],6.087410323088694e-15
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,48805,221,2.69 [2.10-3.43],2.002776686422333e-15
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,51749,105,2.52 [1.80-3.53],7.736804593661846e-08
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51662,304,1.69 [1.35-2.13],6.695203869453891e-06
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Viral warts,51458,100,1.47 [0.97-2.22],0.0660030995100975
CD300E,CMRF35-like molecule 2,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],51487,129,1.91 [1.36-2.68],0.0002003854960007
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm,51204,589,0.95 [0.79-1.14],0.5925313592890622
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51618,115,0.93 [0.62-1.41],0.7355518766086836
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51576,124,0.77 [0.51-1.15],0.1986834727735396
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23826,130,0.87 [0.59-1.27],0.4706410754447137
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",51126,2892,1.09 [1.01-1.18],0.0342658294690857
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of meninges,51764,115,1.63 [1.12-2.38],0.011391482235474
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51662,130,2.01 [1.44-2.81],4.569562008684711e-05
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,51743,212,1.59 [1.21-2.10],0.001045056550502
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm of ovary,27834,180,1.01 [0.73-1.40],0.953846351506642
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Ascending colon,51747,725,1.18 [1.01-1.38],0.0404367372565637
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Caecum,51750,594,1.15 [0.97-1.37],0.110316683214031
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51573,147,0.89 [0.62-1.28],0.5355578432271738
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Descending colon,51741,434,1.02 [0.83-1.25],0.862834329737463
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Rectum,51662,712,1.08 [0.92-1.27],0.3434960435304924
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,51562,1236,1.02 [0.90-1.16],0.7357365836126278
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Benign neoplasm: Transverse colon,51728,864,1.10 [0.95-1.27],0.1894128788277464
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Carcinoma in situ of breast,22637,137,1.08 [0.73-1.58],0.701605902123695
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22730,167,0.79 [0.56-1.14],0.2058212605586689
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",41259,102,1.79 [1.20-2.65],0.0040978581676977
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",41297,140,1.90 [1.36-2.65],0.0001757951348792
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51694,239,1.11 [0.84-1.47],0.4709195061034948
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Haemangioma, any site",51695,234,1.09 [0.82-1.45],0.5425265677972172
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Leiomyoma of uterus,26912,594,1.01 [0.84-1.21],0.9515671270914547
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Lung cancer and mesothelioma,35923,664,1.64 [1.39-1.94],4.950489485886468e-09
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Lymphoid leukaemia,41259,102,1.43 [0.95-2.16],0.0882749132521845
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41536,379,1.07 [0.85-1.34],0.586319123421725
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",41565,408,1.07 [0.86-1.32],0.561444186405502
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22863,188,1.14 [0.83-1.58],0.4078525549246629
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",41318,161,1.32 [0.94-1.84],0.1045380547155973
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",41373,216,1.66 [1.26-2.19],0.0003076561095523
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",41351,194,1.34 [0.99-1.81],0.0559071853340025
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22819,144,1.04 [0.72-1.51],0.8195781462107449
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",41342,185,1.03 [0.74-1.41],0.879933194422636
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19892,1410,1.03 [0.92-1.16],0.6269971169518016
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",41386,229,0.78 [0.58-1.05],0.1058029944780569
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",41305,148,1.15 [0.81-1.63],0.4405958350492814
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,41367,210,1.52 [1.13-2.04],0.0050638451067325
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanocytic naevi,51401,407,1.13 [0.91-1.40],0.2675849993161133
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanocytic naevi of trunk,51714,178,0.99 [0.71-1.38],0.9403145469302892
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Melanoma in situ,41225,164,1.01 [0.71-1.43],0.9473968729851742
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",41339,182,2.07 [1.55-2.76],8.355420597790009e-07
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41476,319,2.09 [1.68-2.60],3.384572038203124e-11
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",41611,454,1.16 [0.95-1.42],0.133281222973269
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",41354,197,2.78 [2.15-3.59],6.846309341219893e-15
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,Other benign neoplasms of skin,51430,308,1.21 [0.94-1.54],0.132641975425243
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",43313,2156,1.23 [1.13-1.35],8.028689581618885e-06
CD300E,CMRF35-like molecule 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",43431,2274,1.22 [1.11-1.33],2.021584832755481e-05
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,51205,685,1.73 [1.48-2.01],2.132583403643213e-12
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,48001,227,7.64 [6.45-9.06],1.5084937711506711e-121
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,50661,141,3.14 [2.36-4.17],3.4497546910091306e-15
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,50197,5806,1.92 [1.82-2.03],1.843177283643589e-126
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,48838,98,3.04 [2.13-4.34],8.095774344096838e-10
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,50955,102,3.25 [2.35-4.51],1.4865526188509882e-12
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,50818,3044,2.10 [1.96-2.26],1.5813622784289344e-94
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,50816,3042,2.10 [1.96-2.26],1.7962565749377695e-94
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,47947,173,2.87 [2.17-3.80],1.8348021625218694e-13
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,51133,2393,1.93 [1.78-2.09],6.474575425497689e-58
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,51082,229,2.46 [1.94-3.14],2.335918584239312e-13
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,50649,129,3.37 [2.52-4.52],4.480057705178158e-16
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,50638,118,1.28 [0.87-1.89],0.2063414058979084
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,51408,555,2.59 [2.23-3.02],4.052501533902932e-35
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,51584,109,3.71 [2.73-5.04],5.023954728179467e-17
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",51310,457,2.59 [2.19-3.06],8.089714207436107e-29
CD300E,CMRF35-like molecule 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,48955,215,2.07 [1.58-2.70],8.913431936093617e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,40066,637,3.77 [3.30-4.32],3.4233778635013054e-84
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,48299,232,1.32 [1.00-1.74],0.0479696978393628
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,48319,252,1.66 [1.28-2.16],0.0001356508170997
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,39536,107,1.81 [1.21-2.72],0.004204455680807
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,48101,137,1.80 [1.29-2.52],0.0006115486144853
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,46961,474,1.61 [1.34-1.95],5.373939786653279e-07
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",50840,1143,1.81 [1.61-2.03],1.8660861910634898e-23
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,50228,531,1.08 [0.90-1.31],0.3995427883050588
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,49954,257,0.69 [0.52-0.91],0.0080451408519247
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,51081,3117,1.36 [1.26-1.47],1.5126436379636368e-15
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,45121,3021,1.40 [1.29-1.51],5.473130271281823e-17
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",39563,134,1.87 [1.31-2.69],0.0006364540637068
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",47755,161,1.49 [1.07-2.08],0.0169338060628276
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,39990,561,2.63 [2.24-3.09],1.3150288179523151e-31
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,39551,122,1.36 [0.91-2.03],0.1277311518159923
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,46519,7090,1.25 [1.19-1.32],1.0590367667742306e-17
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,39823,394,2.50 [2.05-3.05],1.4471825475093682e-19
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,40544,1115,2.16 [1.92-2.44],2.200634542751026e-36
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51628,652,2.43 [2.10-2.81],1.0801062435145488e-32
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,51251,275,3.85 [3.16-4.68],1.3851334954810888e-41
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,39685,256,1.93 [1.48-2.50],8.200576281281338e-07
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",39552,123,3.63 [2.66-4.94],4.0329938816976433e-16
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,50705,3111,1.58 [1.47-1.70],2.936785970934731e-34
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,39948,519,4.84 [4.23-5.55],2.273189376716897e-115
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,40028,599,4.65 [4.11-5.26],2.19017806435034e-131
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",40702,1273,1.42 [1.26-1.61],1.0321874816682495e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,39669,240,2.33 [1.81-3.01],6.65919187349393e-11
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,51234,258,3.80 [3.10-4.65],8.896772990793911e-38
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,40637,1208,2.16 [1.93-2.43],5.497260072735582e-40
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,40393,964,2.04 [1.79-2.32],3.0949905406211443e-26
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,46629,142,2.45 [1.80-3.35],1.5958059480254117e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,49418,9989,1.39 [1.33-1.45],1.5642954663563437e-52
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,47691,97,1.94 [1.30-2.88],0.0011146460409525
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,47705,111,1.43 [0.95-2.14],0.0860925756054924
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,51417,3898,1.21 [1.13-1.30],3.430910860714261e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",51419,3893,1.21 [1.13-1.30],3.2962332127919744e-08
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,47699,105,2.05 [1.41-2.99],0.0001815376740379
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,51104,2408,1.11 [1.01-1.21],0.0233683203543618
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",42599,3170,2.34 [2.19-2.50],4.575492739874367e-135
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,51767,458,3.23 [2.77-3.76],2.183643771975884e-51
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,49865,168,1.48 [1.09-2.03],0.0128299049122734
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,48903,207,1.35 [1.01-1.81],0.0430230413791567
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,48978,282,1.09 [0.84-1.41],0.501948003066874
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",39764,335,1.96 [1.56-2.47],6.659227914641028e-09
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47130,311,2.12 [1.72-2.62],2.7406186331546297e-12
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4254,175,2.67 [2.07-3.43],3.6355811958579204e-14
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4527,505,1.52 [1.28-1.80],2.024029034128679e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,46946,127,4.13 [3.12-5.47],3.6589309164074896e-23
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4191,115,5.80 [4.43-7.61],5.032411672653915e-37
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,50506,3687,1.37 [1.28-1.47],1.00724820547444e-19
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,50402,705,1.43 [1.22-1.66],5.762189113375074e-06
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,47224,737,1.80 [1.55-2.08],8.739436675692366e-15
CD300E,CMRF35-like molecule 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,40980,1551,2.33 [2.11-2.57],4.2865963405668393e-63
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51565,486,1.77 [1.48-2.12],3.393844645842317e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),49530,332,1.94 [1.56-2.41],2.610337324689857e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Angina pectoris,47288,2390,1.46 [1.35-1.59],7.993842518296377e-19
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Aortic aneurysm,49682,484,1.83 [1.53-2.20],8.016782016152572e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,49319,121,3.27 [2.38-4.49],2.506125304909116e-13
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",49601,403,3.21 [2.69-3.82],8.678310387895525e-39
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,32122,3835,1.66 [1.56-1.78],1.5637029004362132e-49
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,AV-block,43622,868,1.68 [1.46-1.94],5.841475162773868e-13
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51674,847,1.49 [1.30-1.71],1.7788074980947226e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiac arrest,28668,381,3.57 [2.93-4.36],4.278638339709287e-36
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43094,340,1.97 [1.58-2.46],1.391764399622088e-09
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",42947,193,2.51 [1.91-3.32],7.030705200773921e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,51790,102,1.70 [1.16-2.50],0.0068829650484599
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Conduction disorders,44864,2110,1.69 [1.54-1.84],2.8335617061871123e-30
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,49039,4177,1.57 [1.47-1.67],1.099573731046864e-44
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,45201,15186,1.25 [1.21-1.30],8.307206428062377e-34
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,49016,525,1.82 [1.53-2.17],1.1179401707605243e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Endocarditis,42902,148,2.22 [1.60-3.08],1.5122658895483852e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",51378,2210,2.21 [2.04-2.39],5.196606926746846e-85
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertension,47037,13041,1.26 [1.21-1.31],1.4677520408687448e-30
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",47072,13076,1.27 [1.22-1.32],2.2350999112652078e-33
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, portal",51445,153,3.94 [3.07-5.06],7.814735767612338e-27
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34347,351,3.15 [2.61-3.79],3.633426256202541e-33
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34273,277,8.19 [7.13-9.40],1.4340831170243436e-196
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Hypotension,51501,2372,1.95 [1.80-2.11],3.61678793051719e-60
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,49945,219,1.32 [0.99-1.75],0.0543585782760424
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",49380,4482,1.50 [1.41-1.60],9.957333472579324e-39
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",51044,1127,1.65 [1.47-1.86],1.0021449126124947e-16
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Left bundle-branch block,43478,724,1.84 [1.58-2.14],3.655492922324662e-15
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50832,1690,1.69 [1.54-1.86],6.3970012908623644e-27
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",46324,1426,1.94 [1.74-2.15],1.5912055065346514e-35
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51604,314,1.67 [1.33-2.08],7.242224435433675e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",51734,625,1.82 [1.56-2.13],7.640606731162104e-14
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Oesophageal varices,48598,107,3.21 [2.30-4.47],6.312263201992863e-12
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other aneurysm,49355,157,1.85 [1.35-2.56],0.0001587537144335
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,43605,851,1.65 [1.43-1.91],9.033712046879556e-12
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,49402,204,3.21 [2.51-4.10],1.3587460475771035e-20
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49679,481,2.49 [2.10-2.95],3.215995024508673e-26
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,43111,357,2.07 [1.67-2.56],1.941446552482151e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other disorders of veins,48686,195,1.90 [1.43-2.52],8.370829341050915e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,48588,97,1.85 [1.24-2.77],0.0028238310546431
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,48906,131,1.55 [1.09-2.21],0.0146671311230173
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,48765,274,1.47 [1.14-1.89],0.0027614848855581
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,44832,2078,1.98 [1.81-2.16],1.3679290756293321e-53
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,49240,111,3.67 [2.68-5.04],6.455803426966973e-16
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,50284,1086,2.44 [2.18-2.73],2.0218137779541383e-54
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50557,693,2.57 [2.25-2.94],1.0485625947169986e-43
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",50008,1233,1.74 [1.55-1.95],7.593419205050302e-22
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28967,680,2.16 [1.83-2.55],9.03706785744441e-20
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49949,814,2.76 [2.44-3.14],1.2589393468833298e-55
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),49179,688,1.56 [1.33-1.82],2.8503486370757372e-08
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50821,957,1.56 [1.37-1.78],4.2436411948631206e-11
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,51649,1319,1.92 [1.72-2.13],1.9171027674069014e-33
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Right bundle-branch block,43454,700,1.81 [1.56-2.12],3.3844537594802285e-14
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50546,682,2.56 [2.24-2.93],1.6329097728263382e-42
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,49165,390,2.55 [2.13-3.06],7.834811935194731e-24
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",51021,1295,1.56 [1.40-1.75],3.9245686042054136e-15
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50979,1372,1.56 [1.40-1.74],1.167943234047559e-15
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,49887,119,1.07 [0.72-1.59],0.751368753818437
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,49359,162,1.67 [1.21-2.31],0.0019963307288603
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50387,470,1.41 [1.17-1.71],0.0003605539371572
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49665,523,1.52 [1.28-1.81],2.66119902848096e-06
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Varicose veins,49338,847,1.56 [1.36-1.80],5.033700012370943e-10
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,49228,174,1.98 [1.46-2.68],1.0626352575445056e-05
CD300E,CMRF35-like molecule 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,51335,1504,1.55 [1.39-1.72],3.138819770076457e-16
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51547,716,1.29 [1.10-1.51],0.0014760293907835
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",45308,2847,1.20 [1.10-1.30],1.422633327889803e-05
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Any mental disorder,50479,8018,1.30 [1.24-1.36],9.5085873158562e-27
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51452,847,1.27 [1.10-1.46],0.0012417662181308
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",45636,3175,1.40 [1.30-1.51],1.5486525132036016e-18
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42641,180,1.43 [1.05-1.96],0.0236747410639801
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Smoking dependency,50718,2743,1.50 [1.38-1.62],2.6371875485878212e-23
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",45727,3266,1.44 [1.34-1.55],3.8271929380661154e-22
CD300E,CMRF35-like molecule 2,Chapter V Mental and behavioural disorders,Vascular dementia,50769,257,1.54 [1.20-1.97],0.0006842987452368
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Alzheimer disease,51791,659,1.05 [0.89-1.24],0.5520101965631137
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",34913,116,1.33 [0.89-2.00],0.1661035510542028
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Bell's palsy,48225,163,1.86 [1.36-2.53],8.595436991652277e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49048,986,1.05 [0.91-1.21],0.5010021776813666
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral cysts,50972,464,1.76 [1.47-2.12],1.752228348184521e-09
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51631,651,1.89 [1.63-2.20],1.109916849605561e-16
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,50785,99,0.69 [0.44-1.08],0.1049128781624475
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,51759,122,1.69 [1.18-2.41],0.004259080502805
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",50658,150,2.12 [1.55-2.88],1.922547142180021e-06
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Epilepsy,48659,576,1.47 [1.24-1.75],1.1054168788476512e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,50828,2745,1.36 [1.25-1.47],1.03995777737914e-13
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,51707,1208,0.96 [0.85-1.09],0.5193602545804107
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,50590,5175,1.43 [1.35-1.51],1.4057664258128849e-33
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Generalized epilepsy,51022,108,1.33 [0.89-1.99],0.1618181212506807
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hemiplegia,51488,508,2.21 [1.87-2.60],2.4901205511235522e-21
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Hydrocephalus,50632,124,0.95 [0.64-1.41],0.8050127185534018
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,51754,138,1.72 [1.22-2.41],0.0017493936038903
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,48208,146,0.92 [0.64-1.34],0.6766657261708061
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,48223,161,1.23 [0.88-1.71],0.2310807596516724
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Memory loss,50478,222,1.35 [1.02-1.78],0.0369430776959893
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Migraine,48800,717,1.21 [1.02-1.42],0.0248069199977626
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51652,644,1.23 [1.03-1.45],0.0199469786363107
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Motor neuron disease,35112,276,0.94 [0.71-1.24],0.6630064799319144
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51458,210,0.94 [0.69-1.28],0.6746587115982612
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",50453,2391,1.20 [1.10-1.31],5.110132120016238e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Neurological diseases,48823,7542,1.25 [1.19-1.32],4.399598146942225e-19
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,51092,406,1.74 [1.43-2.11],1.9766101113338983e-08
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48891,829,1.13 [0.97-1.32],0.1040996354012887
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",51640,591,2.30 [1.97-2.67],6.69761410894343e-27
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,41202,1301,1.30 [1.15-1.46],1.5138547273557782e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,50655,147,1.41 [1.00-1.98],0.0505192162113309
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other disorders of nervous system,50787,279,1.54 [1.21-1.97],0.0004322282336105
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,50828,329,1.27 [1.01-1.60],0.0440130917361759
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other facial nerve disorders,48254,192,1.78 [1.33-2.36],8.836093884994307e-05
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other headache syndromes,48196,113,1.06 [0.70-1.61],0.7687443271012264
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other neurological diseases,51548,1040,1.51 [1.33-1.71],1.7746345203219496e-10
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Other sleep disorders,49204,1121,1.39 [1.23-1.58],1.6170553184117365e-07
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Parkinson's disease,51745,854,0.85 [0.73-0.98],0.0306487562677801
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,50618,110,1.34 [0.89-2.01],0.1660839716747375
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Restless leg syndrome,51791,157,1.14 [0.81-1.61],0.4373840372820693
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Sleep apnoea,51306,965,1.44 [1.26-1.64],7.313152553495556e-08
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Small fibre neuropathy,51147,98,2.74 [1.93-3.89],1.930927697200557e-08
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,51765,332,0.95 [0.75-1.21],0.6716485773939747
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,48162,100,1.04 [0.67-1.60],0.8697345282891736
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,51791,666,1.07 [0.90-1.26],0.4477850162904098
CD300E,CMRF35-like molecule 2,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),50694,250,1.60 [1.24-2.05],0.0002420910820327
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,50644,199,1.21 [0.90-1.63],0.2154827098927705
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,50968,796,0.96 [0.82-1.12],0.5796554972061703
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51443,467,1.83 [1.53-2.19],3.004968038521074e-11
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,49785,106,0.76 [0.49-1.16],0.2041165869802477
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,49795,116,1.03 [0.69-1.55],0.8853544752788641
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",51575,104,1.77 [1.20-2.60],0.0035924678093692
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,51267,294,1.12 [0.87-1.44],0.3866821442781709
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4202,123,5.64 [4.35-7.30],3.5204243856242405e-39
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,5090,206,2.46 [1.97-3.07],3.109660708422432e-15
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,50634,189,1.16 [0.85-1.58],0.3568933064384459
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,51356,2079,1.22 [1.11-1.34],2.449972426471104e-05
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",51061,1382,1.10 [0.98-1.23],0.1187977987246936
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50122,443,1.17 [0.96-1.43],0.128294768350258
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",51621,1449,0.91 [0.81-1.03],0.1278173653038243
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,51772,137,1.31 [0.92-1.87],0.1350261304856171
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,51470,1298,0.89 [0.78-1.00],0.0560463434923338
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",51703,730,1.16 [0.99-1.36],0.059546688726477
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,51604,361,1.15 [0.92-1.44],0.2184538785409166
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,49796,117,1.44 [0.99-2.09],0.0538029095707555
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,49810,131,1.00 [0.69-1.45],0.9887721737414288
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,49786,107,0.84 [0.55-1.29],0.4248956783267089
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,51608,1426,0.89 [0.79-1.00],0.0425870938678062
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,50551,369,0.79 [0.63-0.99],0.0448434272833008
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,50269,97,0.89 [0.57-1.39],0.6020873855689683
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,51172,199,1.38 [1.03-1.85],0.0315196184874924
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,51519,546,1.15 [0.96-1.38],0.139465484059122
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,50560,388,0.74 [0.59-0.93],0.0101416327082977
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,51464,221,1.05 [0.78-1.40],0.7533810559187015
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,51131,949,0.97 [0.84-1.11],0.6280033356615888
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,50727,282,1.38 [1.08-1.76],0.0110427254778919
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,48579,4344,1.18 [1.11-1.26],3.7837574341031657e-07
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,51447,474,1.07 [0.87-1.30],0.523616919601475
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,51751,307,1.46 [1.16-1.85],0.0014338022704548
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50495,816,1.03 [0.88-1.19],0.7302086705802305
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,51102,129,1.21 [0.84-1.75],0.3143691589502095
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,51746,111,1.20 [0.81-1.79],0.3686642807159985
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,49850,171,1.13 [0.81-1.56],0.4761322180753042
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,49978,299,0.91 [0.70-1.17],0.4532992493020011
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,49516,239,1.41 [1.08-1.84],0.0108087625153422
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,50297,125,1.17 [0.80-1.72],0.410079062859186
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",49404,127,0.74 [0.50-1.10],0.140277409829316
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,50358,176,0.77 [0.55-1.07],0.1237844991224901
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",50573,391,0.96 [0.77-1.19],0.679600353750879
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,49934,255,1.17 [0.90-1.52],0.2398328198950462
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,49500,223,0.83 [0.61-1.13],0.2296495792154983
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,49449,172,1.35 [0.98-1.85],0.0658051776162917
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,47859,3624,1.10 [1.03-1.18],0.0076854553287953
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,49820,141,1.11 [0.77-1.59],0.5778679005933697
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,51274,829,1.26 [1.09-1.46],0.0018429739741194
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,50565,120,1.39 [0.96-2.01],0.0829558130153064
CD300E,CMRF35-like molecule 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),50786,341,1.86 [1.51-2.30],7.615762614851181e-09
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,51367,176,1.15 [0.83-1.59],0.4020826971090333
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,51701,239,1.35 [1.03-1.76],0.0297486224286382
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,51527,259,1.33 [1.03-1.72],0.0317929770379698
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,51310,119,1.39 [0.95-2.03],0.0879586467473425
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,51318,127,1.91 [1.34-2.70],0.0002883198200174
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,51595,1804,1.43 [1.30-1.58],2.820530873780887e-13
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,51081,1290,1.50 [1.34-1.68],2.552229219816714e-12
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,50042,251,1.41 [1.09-1.83],0.0090409351155839
CD300E,CMRF35-like molecule 2,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,49965,174,0.89 [0.63-1.24],0.4817489794862838
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute pharyngitis,51303,150,1.92 [1.39-2.64],6.242815100260184e-05
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51579,426,1.64 [1.35-1.99],7.910306272081686e-07
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,51281,128,2.06 [1.47-2.88],2.607374481214607e-05
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza,47741,235,3.22 [2.55-4.07],1.0945473168946093e-22
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),47736,230,3.13 [2.46-3.97],7.108299164696057e-21
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Allergic asthma (mode),35487,228,1.13 [0.83-1.53],0.4300627007609277
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Allergic rhinitis,51525,558,0.97 [0.80-1.17],0.725639853167364
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",38243,3525,1.31 [1.21-1.41],3.129965430643428e-12
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",38730,3471,1.30 [1.20-1.40],1.3555755408582456e-11
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),50980,275,2.60 [2.11-3.22],8.747942559915647e-19
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",47669,163,2.77 [2.08-3.68],2.917896476583918e-12
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Bronchiectasis,44921,708,2.07 [1.79-2.39],9.565732842037698e-23
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",44330,117,1.92 [1.33-2.78],0.0004986851662049
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,49768,5555,1.38 [1.30-1.46],3.303667459874453e-29
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",49043,142,1.04 [0.72-1.50],0.8387579337082196
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,49209,308,0.92 [0.71-1.18],0.4979333281950766
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",51390,2375,1.81 [1.67-1.96],4.170710722759069e-47
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,49116,215,1.03 [0.76-1.39],0.841076036162165
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,47652,10531,1.47 [1.41-1.53],5.730756157665236e-74
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49623,722,1.16 [0.99-1.35],0.0747919078860028
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Early onset COPD,49643,628,2.13 [1.83-2.49],7.844141124282323e-22
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Emphysema,44841,628,2.27 [1.95-2.65],6.487196530342304e-26
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,49192,571,2.22 [1.90-2.59],7.390908142215015e-24
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,51341,3835,2.09 [1.97-2.23],3.613227266477393e-119
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,49261,640,2.22 [1.91-2.57],2.032899512782368e-26
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Later onset COPD,49782,1747,1.68 [1.53-1.85],7.612521957662109e-27
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,51766,657,2.06 [1.78-2.39],2.214321348250808e-22
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Nasal polyp,49116,215,1.10 [0.82-1.47],0.5323591545773357
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,51297,1945,1.82 [1.67-1.99],2.877427358599126e-40
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,51319,3994,1.89 [1.77-2.01],1.9339494352150602e-88
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50565,1664,1.07 [0.96-1.19],0.1965287376194479
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other pleural conditions,47428,103,1.86 [1.24-2.77],0.0024391024049353
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51615,801,2.33 [2.05-2.64],4.623982665693517e-38
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,51579,2600,1.93 [1.79-2.09],2.956744615567765e-65
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural effusion,49318,1993,2.12 [1.94-2.31],1.4386510950499207e-64
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pleural plaque,47636,311,2.00 [1.60-2.49],1.0000113807311823e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",50842,3336,2.12 [1.98-2.26],2.4100806408864146e-108
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,51636,527,2.16 [1.83-2.54],1.4176143077381132e-20
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pneumothorax,47560,235,1.50 [1.14-1.97],0.003575644552046
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pollen allergy,51744,476,0.94 [0.77-1.16],0.5674996638070449
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Pulmonary oedema,50945,131,3.63 [2.76-4.78],3.0012555641120896e-20
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Respiratory insufficiency,35368,109,3.13 [2.15-4.55],2.3920897601403568e-09
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,51253,1901,1.84 [1.69-2.02],2.8980422577353326e-41
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,49461,560,0.97 [0.81-1.18],0.7789001186715105
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Viral pneumonia,48005,499,2.18 [1.82-2.61],1.1391190314526628e-17
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",51010,412,1.95 [1.61-2.36],1.0676058910593568e-11
CD300E,CMRF35-like molecule 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23878,219,1.46 [1.07-1.98],0.0161340478714268
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36582,127,1.79 [1.24-2.57],0.001736631751498
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute appendicitis,51471,292,1.09 [0.84-1.41],0.5195988567963632
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute gastritis,38970,183,2.00 [1.49-2.68],3.320110855467197e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,48094,368,1.50 [1.21-1.86],0.000227172193376
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Acute peritonitis,50840,190,2.70 [2.09-3.50],3.1476780804770344e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Alcoholic liver disease,50003,151,2.43 [1.80-3.28],5.2883617139464325e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Barrett oesophagus,39661,874,1.47 [1.28-1.70],1.0667286577223168e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",47927,201,1.95 [1.49-2.57],1.5565238908076824e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",50944,201,1.89 [1.44-2.48],4.567719285931468e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholecystitis,48133,407,1.58 [1.29-1.93],1.031492438973268e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Cholelithiasis,49716,1990,1.59 [1.45-1.75],2.237914943094098e-23
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Chronic gastritis,39401,614,1.58 [1.34-1.87],7.149547935797335e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Chronic pancreatitis,47826,100,1.64 [1.09-2.45],0.0165729157463521
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",51501,209,3.35 [2.67-4.20],1.4517072928379617e-25
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Coeliac disease,48559,247,2.21 [1.73-2.83],2.183329635589764e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Collagenous colitis,48406,162,1.46 [1.05-2.03],0.0261473103141212
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51488,374,1.29 [1.04-1.60],0.0226004476409618
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Constipation,51274,3362,1.45 [1.35-1.55],2.4398042041997244e-24
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn disease,48431,187,2.41 [1.83-3.17],3.6974721296303826e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51078,137,2.03 [1.46-2.82],2.306575131041225e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48421,177,2.80 [2.13-3.67],1.3078970494988056e-13
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Dental caries,50299,461,1.75 [1.45-2.11],3.675331141637582e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,46489,4456,1.31 [1.23-1.40],9.19663363319524e-17
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of appendix,51546,367,1.10 [0.87-1.38],0.4171275081041441
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of liver,51545,1693,1.82 [1.66-2.01],3.106970408631278e-34
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",47450,8663,1.31 [1.25-1.37],2.13235560500445e-31
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50951,1113,1.40 [1.23-1.58],1.6410166655490756e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51616,966,1.64 [1.44-1.87],9.548682244549629e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50069,231,1.44 [1.10-1.90],0.0085948419219596
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of salivary glands,49771,129,1.38 [0.95-1.99],0.0894821592333794
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,51165,2853,1.47 [1.36-1.59],1.5166062328816062e-22
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diseases of tongue,49802,223,1.36 [1.02-1.80],0.0342155679274057
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",50528,2802,1.57 [1.45-1.70],1.6586474494350694e-30
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,42763,6308,1.22 [1.16-1.29],5.843163756541077e-13
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,39185,398,1.69 [1.38-2.07],3.268532309142913e-07
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51626,320,1.44 [1.15-1.81],0.0014478824766212
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51613,112,1.48 [0.99-2.20],0.0541987523663807
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,50104,252,3.38 [2.75-4.15],4.507711718617729e-31
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36750,295,1.29 [1.00-1.66],0.0524365782927825
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,39887,1100,1.09 [0.95-1.25],0.2037271102390918
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastric ulcer,39508,721,1.46 [1.25-1.71],1.5811044078280202e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,43797,5010,1.29 [1.21-1.37],2.175503277593004e-16
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39865,1078,1.53 [1.35-1.73],3.8030792638010735e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,40087,16603,1.23 [1.19-1.27],2.5948184715197725e-32
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,GI-bleeding,50650,2338,1.45 [1.33-1.58],8.060946746000364e-18
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,49947,109,1.36 [0.91-2.03],0.1370412055676224
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,38413,2527,1.22 [1.12-1.34],7.348776686826848e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",49979,127,2.66 [1.94-3.66],1.553906649487829e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Hernia,48526,6493,1.24 [1.18-1.31],5.465490689889127e-16
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Impacted teeth,51626,104,1.57 [1.05-2.37],0.0298534185680011
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Impaction of intestines,36566,111,2.10 [1.45-3.06],0.0001008833018644
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Inguinal hernia,43835,1802,1.13 [1.02-1.25],0.0150021161242838
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",42238,205,1.03 [0.76-1.40],0.8472151010066855
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,36649,194,1.43 [1.05-1.94],0.0227084679926298
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48598,286,2.14 [1.70-2.70],8.290142659783727e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,37559,1104,1.31 [1.15-1.49],7.098080740459472e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,51735,742,1.62 [1.39-1.88],2.5954658604451253e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49757,1513,1.55 [1.39-1.72],4.587233073228624e-16
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,50261,2017,1.53 [1.40-1.68],6.985650056287978e-20
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39161,374,1.67 [1.35-2.06],2.123439667890605e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oesophagitis,39997,1210,1.47 [1.31-1.66],2.559520182908149e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51691,269,1.06 [0.81-1.39],0.6525796932309939
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,42171,138,1.41 [0.98-2.01],0.0609930835354405
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,39186,2731,1.31 [1.21-1.42],1.169075521606444e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,48287,561,1.46 [1.22-1.73],2.572493224115304e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,48039,313,1.16 [0.91-1.48],0.2395139810943994
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,39957,3502,1.28 [1.19-1.38],1.588116942258328e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,47758,11303,1.27 [1.22-1.32],9.108665789977991e-31
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49753,410,1.06 [0.85-1.32],0.5988446544345122
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of liver,51237,1385,1.80 [1.61-2.00],1.0083071075253151e-26
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,40113,1326,1.45 [1.29-1.63],2.886195461815093e-10
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of pancreas,48029,303,2.26 [1.82-2.80],1.4389643925568124e-13
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,51477,827,1.43 [1.24-1.66],1.2164434013135507e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,40701,1914,1.70 [1.55-1.87],4.664523847365877e-29
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,50681,2369,1.45 [1.33-1.58],5.074014541307922e-18
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50213,375,1.18 [0.94-1.47],0.1484374123761493
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,39911,3456,1.52 [1.41-1.63],7.355680077320143e-31
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),42807,4020,1.44 [1.35-1.54],3.0785220529465696e-27
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,50051,199,2.16 [1.65-2.83],2.179073400484394e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,50013,1769,1.53 [1.39-1.69],1.1454508779908885e-17
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",37147,692,1.62 [1.39-1.90],1.3879613564939587e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51594,132,1.54 [1.07-2.21],0.021023746925949
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,37439,984,1.65 [1.45-1.88],7.804680319854606e-14
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48613,301,1.60 [1.27-2.03],8.126266449102081e-05
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Recurring oral aphthae,51769,113,1.56 [1.06-2.28],0.0239169575513961
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,49848,235,1.45 [1.11-1.91],0.0071454072709019
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Toxic colitis,48358,114,1.64 [1.12-2.40],0.0111965948071589
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39317,530,1.53 [1.28-1.83],2.927355845417716e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,48566,322,1.97 [1.58-2.45],1.733058252138225e-09
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48511,267,1.98 [1.56-2.52],2.7713014931656786e-08
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Umbilical hernia,42581,548,1.19 [0.99-1.43],0.0605281200302183
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,36808,353,2.04 [1.65-2.52],5.906518199456701e-11
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Ventral hernia,42553,520,1.54 [1.29-1.85],2.6086139899630537e-06
CD300E,CMRF35-like molecule 2,Chapter XI Diseases of the digestive system,Volvulus,36617,162,1.63 [1.17-2.26],0.0036174115713323
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,51629,596,1.15 [0.96-1.36],0.1269213923839935
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,51140,146,2.05 [1.49-2.81],8.862912279194849e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47687,323,0.90 [0.70-1.16],0.4241133892886555
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,50518,1404,2.03 [1.83-2.25],1.6161446181760875e-41
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49465,351,1.61 [1.29-2.01],2.071118326629148e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,48176,812,2.53 [2.23-2.88],3.3319380418702704e-45
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,51173,554,1.59 [1.34-1.90],1.339611943311118e-07
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51587,968,1.80 [1.58-2.04],1.4326824718598852e-19
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,50716,97,2.57 [1.77-3.72],6.893651956269894e-07
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,48677,6429,1.42 [1.35-1.50],1.1744370544882994e-39
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,50887,901,1.02 [0.88-1.18],0.8088863733340836
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50619,633,0.91 [0.76-1.08],0.2709699397769045
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,51007,1893,1.86 [1.70-2.04],1.3753367443109963e-41
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",51759,108,1.47 [0.98-2.18],0.0603437389780239
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,47479,115,4.00 [2.99-5.35],1.035853211846722e-20
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50091,105,1.93 [1.34-2.80],0.0004772107249586
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,51152,533,1.54 [1.29-1.84],1.834233016685172e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,48273,909,1.21 [1.04-1.39],0.0108854427595023
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,47492,128,1.58 [1.10-2.28],0.0137779706404476
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,51618,167,2.03 [1.51-2.72],2.988199723623293e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,49485,371,2.40 [1.98-2.91],5.420661474210904e-19
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51384,390,1.47 [1.19-1.80],0.0003116799516644
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,50750,131,2.86 [2.09-3.93],6.892932366267325e-11
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,47498,134,1.10 [0.75-1.60],0.6324416085244567
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,50635,3271,1.56 [1.45-1.68],3.5085455796559763e-34
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",48351,987,1.25 [1.09-1.43],0.0017338132010967
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,47500,136,1.61 [1.13-2.29],0.0088770457693335
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51612,618,1.51 [1.28-1.79],8.039418183243264e-07
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,50758,139,1.95 [1.41-2.70],6.251661356368771e-05
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51500,506,1.54 [1.29-1.85],3.003007508052856e-06
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51684,651,1.12 [0.95-1.33],0.177269740075313
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47617,253,0.87 [0.65-1.16],0.342445397995749
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47901,537,0.93 [0.77-1.13],0.4761040686586588
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51663,630,1.14 [0.96-1.35],0.1304457513971307
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",47840,476,3.15 [2.69-3.68],6.166363629449373e-47
CD300E,CMRF35-like molecule 2,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,51730,279,1.69 [1.33-2.15],1.6511076607176035e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,44441,220,1.19 [0.88-1.59],0.2528876626399479
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,47145,11304,1.22 [1.17-1.27],4.432399112531636e-22
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,44315,8474,1.17 [1.11-1.22],2.3060669744985914e-10
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,44374,153,0.94 [0.65-1.35],0.7404467044274858
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44905,309,1.26 [0.99-1.61],0.0606268979175391
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44956,360,1.79 [1.45-2.20],7.113816142767338e-08
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,51291,183,1.11 [0.81-1.54],0.5153608589655585
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",44793,197,1.80 [1.35-2.39],5.142162658076036e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,38111,2270,1.15 [1.05-1.26],0.0034287139542977
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51516,379,1.09 [0.88-1.36],0.4237792798878171
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,45489,893,1.16 [1.00-1.34],0.0493991533747653
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,43783,14547,1.19 [1.15-1.23],2.372945313400858e-20
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47828,233,1.55 [1.18-2.03],0.0017046043518132
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,44523,302,1.77 [1.41-2.22],8.339786426095231e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,45356,1135,0.97 [0.85-1.11],0.6633406986098478
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,49932,5336,1.20 [1.13-1.27],2.400707746125873e-09
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44768,547,1.02 [0.84-1.23],0.8583766060534368
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,44660,439,1.60 [1.30-1.96],6.05852127732256e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44488,267,0.78 [0.59-1.04],0.0888412450790357
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,50506,138,1.12 [0.77-1.63],0.5431241780608127
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,39231,3390,1.11 [1.02-1.19],0.0099452218753695
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,37057,1216,2.50 [2.24-2.78],1.5331267054383262e-63
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",51638,1199,2.39 [2.15-2.66],5.1891471256646016e-58
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,35992,151,0.55 [0.38-0.81],0.0026329746401758
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36500,659,1.17 [0.98-1.39],0.0838757954087453
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44831,610,0.88 [0.73-1.05],0.1617621582477559
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,37121,1280,1.03 [0.90-1.17],0.6829257046993289
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,44707,111,2.21 [1.54-3.18],1.5626454556310726e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45858,1262,1.34 [1.19-1.51],1.2078381734952902e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,45208,612,1.14 [0.95-1.36],0.1549171990674789
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,37037,1196,0.98 [0.86-1.12],0.8038268616282883
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,44382,161,1.48 [1.07-2.06],0.0186402216060001
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",44343,122,1.48 [1.01-2.16],0.0430118967620739
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,47738,143,2.72 [2.02-3.66],4.774315348367403e-11
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,51014,3419,1.41 [1.31-1.52],6.229516655235746e-21
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,49828,2233,1.41 [1.29-1.54],8.146165520145913e-14
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51503,906,2.23 [1.97-2.53],1.92255263660766e-35
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,40825,4984,1.31 [1.23-1.39],1.859634297632152e-17
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,35966,125,0.90 [0.59-1.36],0.6186045234467016
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,44409,188,1.70 [1.26-2.29],0.0004604861068804
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,35939,98,1.62 [1.06-2.49],0.0265211811156766
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36090,249,1.36 [1.03-1.79],0.0312656834666292
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,48079,484,1.24 [1.02-1.51],0.0327834560800129
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,48354,759,1.59 [1.37-1.85],2.610459381240035e-09
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,51726,202,1.49 [1.11-1.99],0.0070435814712588
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",48209,3613,1.21 [1.12-1.30],2.643810226320507e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44421,200,1.28 [0.94-1.74],0.1107412346668396
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36117,276,1.53 [1.18-1.99],0.0012602984777043
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,46046,1450,1.11 [0.99-1.25],0.0697097483664429
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,40155,4314,1.24 [1.16-1.33],1.3866110727728753e-10
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,50554,186,1.70 [1.26-2.29],0.0005449697384587
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,51753,139,2.15 [1.56-2.96],2.8653733930316567e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44381,160,1.01 [0.72-1.43],0.9448540511546408
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",46715,2494,1.54 [1.42-1.67],5.571487878969467e-25
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,44401,180,1.74 [1.29-2.35],0.0002581529626003
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,39081,3240,1.31 [1.21-1.41],5.752054461319322e-12
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47819,224,1.08 [0.81-1.46],0.5888636632946942
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,44330,109,0.90 [0.58-1.40],0.6475810286019841
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,44913,317,1.07 [0.84-1.37],0.5977068877021259
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,45328,1107,1.85 [1.65-2.08],1.2789592162714415e-24
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,51073,705,1.91 [1.64-2.22],2.483431180073325e-17
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45746,1150,1.41 [1.25-1.60],3.9044729407878644e-08
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51527,880,2.30 [2.02-2.61],2.2407404098190133e-37
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,51749,109,3.38 [2.46-4.64],5.212087476892162e-14
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44605,384,1.24 [0.99-1.54],0.0583571988924034
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,41007,1514,1.61 [1.44-1.79],3.143923326303009e-18
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,45390,1169,1.52 [1.35-1.71],1.1273865617132748e-11
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44679,458,1.00 [0.81-1.22],0.9777853247022256
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",35949,108,1.19 [0.78-1.83],0.4178219563903698
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,40816,4975,1.52 [1.43-1.62],1.1691059972009728e-43
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,37154,1313,1.33 [1.18-1.50],2.540477359886803e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,50830,462,1.19 [0.97-1.45],0.0930347128504451
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",51658,134,1.92 [1.37-2.70],0.0001488162189148
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",47455,100,1.32 [0.88-1.97],0.1794912873118306
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,35983,142,2.33 [1.67-3.25],6.150787386491616e-07
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,44801,205,0.97 [0.71-1.32],0.8269420074650721
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36760,919,2.41 [2.12-2.74],5.203931221017792e-41
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44835,614,1.01 [0.84-1.20],0.9338662634837904
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,45101,505,1.26 [1.04-1.52],0.0184232617930648
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,44973,377,1.22 [0.98-1.52],0.0797859946551459
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,40514,118,1.49 [1.00-2.22],0.0478722040701006
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",51757,117,3.42 [2.52-4.64],3.115757326827186e-15
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,45402,1181,1.02 [0.90-1.16],0.7834132969065145
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],50551,183,4.24 [3.39-5.31],1.984116754067475e-36
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,49371,5150,1.25 [1.17-1.32],3.311383220834344e-13
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44483,262,1.32 [1.01-1.71],0.0403506649968382
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,45685,1089,1.22 [1.07-1.39],0.0022609889458792
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,48967,469,1.14 [0.93-1.39],0.1999010547560102
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,45012,416,0.91 [0.73-1.13],0.3967902639246353
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,47717,3121,1.21 [1.12-1.31],1.0699197977652886e-06
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,46653,2057,1.23 [1.12-1.35],1.4414231782912048e-05
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],44330,109,1.45 [0.97-2.17],0.0687235366514053
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50637,269,3.92 [3.25-4.72],6.1787112129308685e-47
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44543,322,0.97 [0.76-1.25],0.835923914315184
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,44370,149,1.19 [0.84-1.70],0.3347395194973215
CD300E,CMRF35-like molecule 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),35957,116,1.83 [1.25-2.69],0.0021094485314651
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,49686,3155,3.36 [3.15-3.60],8.569895632177378e-273
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20897,103,1.15 [0.74-1.77],0.5368923123505946
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27206,113,1.23 [0.81-1.86],0.3329230110418525
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51151,647,1.34 [1.13-1.58],0.0005222102824892
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,50670,166,1.26 [0.91-1.74],0.1667167212765775
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,49593,3062,4.68 [4.40-4.99],0.0
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,51357,168,8.28 [6.98-9.81],2.4379609593137954e-131
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,51295,607,1.91 [1.63-2.24],2.673298689437004e-15
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Cystitis,45614,466,1.54 [1.27-1.87],1.0177131801387917e-05
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Dialysis,46691,160,17.43 [14.75-20.59],1.6959707258173102e-247
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22579,3339,1.06 [0.99-1.15],0.1064341603648582
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27437,344,1.30 [1.03-1.64],0.0274834007421735
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,20978,184,1.13 [0.81-1.57],0.4804851164307674
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",21196,402,1.02 [0.81-1.28],0.8768244417207839
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21821,1027,1.06 [0.93-1.22],0.3964027287237494
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,43217,10757,1.51 [1.45-1.58],2.811263718873477e-82
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,51359,170,6.94 [5.58-8.62],3.3523026324298228e-68
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,19445,205,0.83 [0.60-1.13],0.2306652077220606
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,46514,586,2.01 [1.68-2.41],1.7155478261263742e-14
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21867,2627,1.07 [0.98-1.16],0.1116304001945756
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27358,405,1.05 [0.84-1.31],0.6444279417171855
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19475,235,1.05 [0.79-1.39],0.7375727755872229
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,27444,131,0.65 [0.42-0.98],0.0403758679670703
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21102,308,1.26 [0.97-1.63],0.0819852962342686
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45306,158,1.73 [1.25-2.38],0.0008819871861314
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,23294,2500,1.10 [1.00-1.20],0.0411556859965531
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19349,109,1.42 [0.96-2.10],0.0804161515306059
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20937,143,1.51 [1.06-2.16],0.02200710726896
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",51765,125,1.27 [0.88-1.85],0.1993122785121419
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",51775,133,1.44 [1.01-2.05],0.044385106680376
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,49693,4545,1.53 [1.44-1.62],1.2044551865962833e-42
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,46579,1431,1.19 [1.06-1.33],0.0027179514197591
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27212,119,1.29 [0.87-1.92],0.1990244218356632
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51653,965,2.42 [2.14-2.72],1.1689009558210836e-47
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19552,312,1.18 [0.93-1.50],0.1798920476404646
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19523,283,1.19 [0.93-1.54],0.1706364020348871
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19469,229,0.94 [0.70-1.25],0.6625516241466232
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,51711,140,1.67 [1.20-2.34],0.0026554008533062
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,48653,3505,1.72 [1.61-1.84],1.5220942263675703e-55
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27163,210,1.18 [0.87-1.60],0.2865806297416576
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20950,156,0.82 [0.57-1.18],0.2878799379252012
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21171,377,1.12 [0.89-1.40],0.3392290671571657
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20907,113,1.10 [0.73-1.67],0.6367024932316014
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21003,209,0.89 [0.65-1.21],0.4643294299883485
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46612,684,2.26 [1.92-2.65],4.231076819440529e-23
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,51007,319,2.83 [2.32-3.46],1.0111061356640755e-24
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21107,313,1.07 [0.84-1.38],0.5731788304318639
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20903,109,1.09 [0.71-1.67],0.7042680784077529
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21453,659,1.02 [0.85-1.21],0.8578981369210612
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20955,161,1.30 [0.93-1.81],0.1234570482312482
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21391,597,1.03 [0.86-1.24],0.7108620509328681
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,51286,97,3.88 [2.79-5.42],1.2131279055571656e-15
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19507,267,1.29 [1.00-1.67],0.0499311428488722
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,51284,5356,2.99 [2.84-3.15],0.0
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",46170,242,3.66 [2.87-4.67],1.91264757386702e-25
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46793,262,6.42 [5.28-7.80],4.1667217206411374e-78
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50616,112,1.20 [0.80-1.80],0.3723851276709344
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45593,445,1.87 [1.55-2.26],5.944790454625169e-11
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51301,797,1.28 [1.11-1.49],0.0009826110937204
CD300E,CMRF35-like molecule 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20937,143,1.04 [0.71-1.51],0.8497991697949776
